Isabella Maria Acquistapace (Isabella M Acquistapace)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Escherichia Coli

Candida Albicans

Top Venues

Journal of medicinal chemistry

The Journal of biological chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Isabella Maria Acquistapace, Maria Antonietta La Serra, José Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry (2023)
Isabella Maria Acquistapace, Emma J Thompson, Imke Kühn, Michael R Bedford, Charles A Brearley, Andrew M Hemmings
Insights to the Structural Basis for the Stereospecificity of the Escherichia coli Phytase, AppA. International journal of molecular sciences 23 (11) (2022)
Isabella Maria Acquistapace, Monika Ziętek, Arthur W H Li, Melissa Salmon, Imke Kühn, Mike R Bedford, Charles A Brearley, Andrew M Hemmings
Snapshots during the catalytic cycle of a histidine acid phytase reveal an induced fit structural mechanism. The Journal of biological chemistry (2020)